Agenda
The following agenda is for the 2025 Indy Hematology Review event.
Saturday, March 8th, 2025
| Time | Event/Topic |
|---|---|
| 6:00 AM - 10:00 AM | Registration |
| 6:45 AM - 7:25 AM | Breakfast @ Product Theater |
Precursory Events
Session 1
| Time | Event/Topic |
|---|---|
| 7:30 AM-8:00 AM | State of the Art: 2025: Emerging Therapies in Hematologic Malignancies - Ruemu Birhiray, MD |
| 8:00 AM- 8:40 AM | Treatment of Acute Myeloid Leukemias |
| 8:00 AM- 8:20 AM | Treatment Options for Newly Diagnosed Patients - Daniel Pollyea, MD, MS |
| 8:20 AM- 8:40 AM | Current and Emerging Therapies for Relapsed AML - Rami Komrokji, MD |
| 8:40 AM - 9:00 AM | Hematopoietic Transplantation and Cellular Therapies: When to Refer - Richard Childs, MD |
| 9:00 AM - 9:20 AM | Management of Chronic Myeloid Leukemia in 2025 - Richard Larson, MD |
| 9:20 AM - 9:30 AM | Myeloid and Lymphoblastic Leukemias - PANEL DISCUSSION |
| 9:30 AM- 9:45 AM | Coffee Break - Exhibit Hall |
| 9:45 AM - 10:05 AM | Approaches to the Management of Newly Diagnosed Multiple Myeloma - Saad Usmani, MD, MBA |
| 10:05 AM-10:25 AM | Emerging and Current Treatment of Relapsed/Refractory Multiple Myeloma - Kenneth Anderson, MD |
| 10:25 AM -10:45 AM | Current Approaches to the Treatment Waldenstrom's Macroglobulinemia - Steven P. Treon, MD, MA, PhD, FRCP, FACP |
| 10:45 AM-11:05 AM | Evaluation, Diagnosis and Treatment of Amyloidosis: Approaches Including and Beyond Anti-CD38 Antibody Therapy - Morie Goertz, MD, MACP |
| 11:05 AM-11:15 AM | Plasma Cell Disorders - PANEL DISCUSSION |
| 11:15 AM- 11:25 AM | Coffee Break - Exhibit Hall |
| 11:25 AM-11:45 AM | Treatment of Complementopathies: Diagnosis and Therapeutic Strategies - Robert Brodsky, MD |
| 11:45 AM - 12:05 PM | How to treat: Options and Treatment Paradigms for Aplastic Anemia - Neal Young |
| 12:05 PM-12:25 PM | Classical Hematology: Managing Disorders of Bleeding and Clotting - Craig Kessler, MD, MACP |
| 12:25 PM - 12:45 PM | Treatment Options and Cellular Therapy for Sickle Cell Disease - Matthew Hsieh, MD |
| 12:45 PM-12:55 PM | Hematology - PANEL DISCUSSION |
| 1:05 PM - 1:50 PM | Luncheon Product Theaters |
| 1:50 PM - 2:00 PM | Coffee Break - Exhibit Hall |
Session Chair: Ruemu E. Birhiray, MD
Session 2
Session Chair: Michael Wiemann, MD, FACP
| Time | Event/Topic |
|---|---|
| 2:00 PM- 2:45 PM | T. Howard Lee Keynote Lecture: When Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma - Christopher Flowers, MD, MS, FASCO |
| 2:45 PM-3:05 PM | Chronic Myelomonocytic leukemia: Diagnosis, Prognostication, and Treatment - Ayalew Tefferi, MD |
| 3:05 PM- 3:25 PM | Current and Emerging Treatment Options of Myeloproliferative Neoplasms - Ayalew Tefferi, MD |
| 3:25 PM- 3:30 PM | Myeloproliferative Neoplasms - PANEL DISCUSSION |
| 3:30 PM- 3:50 PM | How I Choose: Current Approaches to Frontline Treatment of Chronic Lymphocytic Leukemia - Jennifer Woyach, MD |
| 3:50 PM - 4:10 PM | Annual Steven Coutre Chronic Lymphocytic Leukemia Memorial Lecture: Emerging and Current Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia - John Byrd, MD, FACP |
| 4:10 PM - 4:20 PM | Coffee Break - Exhibit Hall |
| 4:20 PM - 4:40 PM | My Approaches to Managing the Controversies in the Treatment of Mantle Cell Lymphomas - Michael Wang, MD, PhD |
| 4:40 PM - 5:00 PM | Emerging and Current Treatment for Hodgkin Lymphoma - Stephen Ansell, MD, PhD |
| 5:00 PM - 5:35 PM | Current Advances in the treatment of Aggressive B and T Cell Lymphomas - Sonali Smith, MD, FASCO |
| 5:35 PM -5:55 PM | Bispecific Antibody Therapy for Lymphoid Malignancies - Tycel Phillips, MD |
| 5:55 PM - 6:15 PM | Cellular Therapy for Lymphoid Malignancies - Matthew Lunning, DO, FACP |
| 6:15 PM - 6: 35 PM | Bispecific and Cellular Therapy for Multiple Myeloma - Joselle Cook, MD |
| 6:35 PM - 7:10 PM | The Great IHR 2025 Debate: Controversies in the Treatment of the AYA Patient with Acute Lymphoblastic Leukemia: Pediatric Inspired Chemotherapy Regimens - Richard Stone, MD IO HyperCVAD Inspired Targeted Regimens - Hagop Kantarjian, MD |
| 7:10 PM - 7:20 PM | Lymphoid Malignancies and Cellular Therapies - PANEL DISCUSSION |
| 7:20 PM - 7:40 PM | Reception with Hors D'oeuvres and Beverages |
| 7:40 PM - 8:40 PM | Hematologic Malignancies Townhall |
| Ruemu E. Birhiray, MD – Chair and Moderator | |
| Michael Wiemann, MD, FACP – Co-Chair | |
| Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis | |
| Jennifer Woyach, MD – Chronic Lymphocytic Leukemia | |
| Richard Stone, MD, IO – Acute Leukemias and Myelodysplastic Syndromes | |
| Christopher Flowers, MD, MS, FASCO – Lymphomas | |
| Saad Usmani, MD, MBA – Multiple Myeloma | |
| Joselle Cook, MD – Multiple Myeloma | |
| Ayalew Tefferi, MD – Myeloproliferative Neoplasms |